SCHEMBL23686149

SCHEMBL23686149

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4c3sc3cccc(-c5ccc(-c6nc(-c7ccccc7)nc7c6oc6ccccc67)cc5)c34)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.43
ALDH1A1 P00352 8/20 0.43
KDM4E B2RXH2 3/20 0.43
POLB P06746 3/20 0.43
NPSR1 Q6W5P4 4/20 0.42
TSHR P16473 5/20 0.41
HPGD P15428 2/20 0.41
LMNA P02545 5/20 0.40
HSD17B10 Q99714 3/20 0.40
MAPK1 P28482 2/20 0.40
KMT2A Q03164 7/20 0.39
USP2 O75604 1/20 0.39
HTT P42858 1/20 0.39
MEN1 O00255 6/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
GAA P10253 2/20 0.38
LIMK1 P53667 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22195841 0.96 MAPT (0.43) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL25018092 0.96 MAPT (0.43) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL22330114 0.96 MAPT (0.41) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL25016315 0.96 MAPT (0.43) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL22330113 0.96 MAPT (0.41) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL22196116 0.96 MAPT (0.43) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL22330007 0.96 MAPT (0.43) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL25017068 0.95 MAPT (0.44) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL25016314 0.94 MAPT (0.42) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL22195919 0.94 MAPT (0.42) MAPTALDH1A1KDM4EPOLBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210230182-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210230182-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CRY2, CYP1A1 MAPT 660/4885ALDH1A1 21/4885KDM4E 3325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.